1 AIT Asian Institute of Technology

Launching of pharmaceuticals into the Thai market

AuthorNapapan Meepadung
Call NumberAIT RSPR no. SM-99-27
Subject(s)Drugs--Marketing--Thailand

NoteA research study submitted in partial fulfillment of the requirements for the degree of Master of Business Administration, School of Management
PublisherAsian Institute of Technology
AbstractIn Thailand, the market of Aspirin is very promising due to its indication. In general, Aspirin is widely recognized as an analgesic product, which mean chemical substances, which indicated, for relieving pain. Long used to relieve pain, reduce fever, lessen stiffness, and inflammation, Aspirin is now widely used to prevent heart attacks and strokes. Even low doses of Aspirin can reduce the incidence of these cardiovascular events as it contains acetylsalicylic acid, which acts as platelet aggregation inhibitor (makes it more difficult for the platelets to accumulate and thus reduce the risk of clot formation). In order to market this drug successfully, an accurate preliminary plan is needed. Medical doctors play a crucial role as the major initiators in purchasing decision. As a result, their prescriptive behaviors are vital in this study. The problem of this research is to prove if the positive side effect of aspirin in being prescribed for the prevention and treatment of coronary heart disease in order to analyze the findings and give suggestions on product attributes and promotional campaign for marketing this drug. Personal and mailing interviews with one hundred and thirty-five senior doctors were conducted. Ninety-four of the respondents in the sample size are cardiologists, which is accounted for seventy percent of total sample size. Twenty-one of total sample size are neurologists, occupies fifteen percent of overall sample size. The rest twenty of them are general practitioners, which is accounted for fifteen percent of total sample size. Personal interviews with pharmacy supervisors/purchasing department of hospitals also were conducted for additional information in terms of organizational buying behavior as well as (drugs) buying criteria. According to the survey, doctors (who are practicing as cardiologists, neurologists, and general practitioners) agreed with the indication of aspirin on anti-platelet therapy. As a result, most of patients suspected with coronary heart disease are recommended to take aspirin once daily. In terms of product attribute, aspirin as the indication of anti-platelet therapy should have faster mode of action and faster solubility. It might be possible that a cert~in substance should be contained in those aspirin. Large quantity of this drug, for example the bottles of 1,000 tablets should be provided for the hospital channels. For promotional campaign, symposium should be considered in order to provide medical proof/data on the particular drug. Price discounts should also be taken into accounted for aspirin against coronary heart disease as almost all patients (except contradiction is found) suspected with this particular disease are recommended to take this particular drug once daily. Such sport tournaments as aspirin-heart mini-marathon, aspirin-heart tennis tournament, or aspirin-heart golf tournament should be sponsored in order to build product and brand awareness.
Year1999
TypeResearch Study Project Report (RSPR)
SchoolSchool of Management
DepartmentOther Field of Studies (No Department)
Academic Program/FoSMaster of Business Administration (MBA) (Publication code=SM)
Chairperson(s)Bechter, Clemens;
Examination Committee(s)Tang, John C.S.; Swierzeck, Fredric William ;
Scholarship Donor(s)Asian Institute of Technology (Partial Scholarship);
DegreeResearch studies project report (M.B.A) - Asian Institute of Technology, 1999


Usage Metrics
View Detail0
Read PDF0
Download PDF0